↓ Skip to main content

American Association for Cancer Research

Article Metrics

Phase I Study of High-Dose l-Methylfolate in Combination with Temozolomide and Bevacizumab in Recurrent IDH Wild-Type High-Grade Glioma

Overview of attention for article published in Cancer Research Communications, January 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
10 news outlets
blogs
4 blogs
twitter
29 tweeters

Readers on

mendeley
5 Mendeley